Which ETFs hold PRCT? Procept Biorobotics Corp is held by 1 fund tracked by ETFpeek.

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 7 Aug 2026 | Larry L Wood President, CEO & Director | BUY | Discretionary | 23,900 | $498K | 80 |
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 2 Oct 2026 | Michael Mack Director / Other | BUY | Vested (RSU) | 19,918 2 tranches | — | 0 |
| 13 Aug 2026 | Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary | BUY | Vested (RSU) | 54,738 2 tranches | — | 30 |
| 13 Aug 2026 | Barry L Templin Executive VP & CTO | BUY | Vested (RSU) | 62,558 2 tranches | — | 30 |
| 13 Aug 2026 | Kevin Waters Executive VP & CFO | BUY | Vested (RSU) | 70,378 2 tranches | — | 30 |
| 13 Aug 2026 | Pooja Sharma Executive VP and Chief Strategy & Marketing Officer | BUY | Vested (RSU) | 56,303 2 tranches | — | 30 |
| 7 Aug 2026 | Larry L Wood President, CEO & Director | BUY | Discretionary | 23,900 | $498K | 80 |
| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 11 Sep 2026 | BOTZ | BUYAdded | +9,857 | +0.03% | 2.04% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||